データなし
データなし
Psyence Group Closes Disposal of PsyLabs Stake; Shares Fall
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press Release: Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs
Psyence Biomedical Shares Are Trading Higher After the Company Announced the Recruitment of Its Australia-based Empax Center as the Second Trial Site for Psyence's Biomed Ongoing Phase IIb Clinical Trial of Nature-derived Psilocybin as a Potential...
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
6-K:海外発行者報告書(決算情報)
データなし
データなし